The Impact of Lebrikizumab on Vaccine-Induced Immune Responses: Results from a Phase 3 Study in Adult Patients with Moderate-to-Severe Atopic Dermatitis
DERMATOLOGY AND THERAPY（2024）
Key words
Atopic dermatitis,IL-13,Lebrikizumab,MCV,Tdap,Vaccine response
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined